EpiSign and Geneyx join forces to merge DNA methylation analysis with multi-omics platforms, aiming to improve diagnostic precision and expand market reach for both firms.
EpiSign Inc. announced a partnership with Geneyx to integrate DNA methylation analysis, which may expand its market reach.
Geneyx Genomex Ltd. partnered with EpiSign to integrate genomic and epigenomic analysis, potentially enhancing its platform's capabilities.
EpiSign Inc. and Geneyx Genomex Ltd. have entered a strategic partnership to integrate DNA methylation episignature analysis into the Geneyx multi-omics platform. This collaboration aims to enhance genomic diagnostic capabilities by combining specialized epigenomic data with comprehensive multi-omics analysis tools.
The partnership aims to integrate EpiSign's DNA methylation analysis with the Geneyx multi-omics platform to provide more comprehensive genomic and epigenomic insights.